Applied Discovery

Applied Discovery is a San Diego-based biotechnology company focused on transforming small molecule drug discovery through an integrated platform that combines DNA-encoded libraries (DEL) with machine learning. The company's proprietary technology enables the rapid synthesis and screening of billions of compounds to identify high-affinity ligands for challenging and previously "undruggable" biological targets. By leveraging advanced computational models to analyze vast datasets generated from their DEL screens, Applied Discovery aims to accelerate the hit-to-lead process and improve the success rate of drug development. The firm is currently applying its scalable, data-driven approach to internal discovery programs and potential partnerships across multiple therapeutic areas.